The deadly impact of extreme drug resistance in Acinetobacter baumannii.
about
Structure of shikimate kinase, an in vivo essential metabolic enzyme in the nosocomial pathogen Acinetobacter baumannii, in complex with shikimatePolymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections.The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii.The role of conserved surface hydrophobic residues in the carbapenemase activity of the class D β-lactamases.Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.Genetic Regulation of Virulence and Antibiotic Resistance in Acinetobacter baumanniiThe First Cut Is the Deepest: The History and Development of Safe Treatments for Wound Healing and Tissue Repair.Crystal structure of 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase from the ESKAPE pathogen Acinetobacter baumannii.Do Results of Surveillance Cultures Impact the Choice of Empirical Antibiotics Among Patients with Carbapenem-Resistant Acinetobacter baumannii Infections?If antibiotics did not exist.Surveillance cultures growing carbapenem-Resistant Acinetobacter baumannii predict the development of clinical infections: a retrospective cohort study.Light Modulates Metabolic Pathways and Other Novel Physiological Traits in the Human Pathogen Acinetobacter baumannii.SPR741, an Antibiotic Adjuvant, Potentiates the In Vitro and In Vivo Activity of Rifampin against Clinically Relevant Extensively Drug-Resistant Acinetobacter baumannii.Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.Integration of Temperature and Blue-Light Sensing in Acinetobacter baumannii Through the BlsA Sensor.Attributable Risk and Time Course of Colistin-Associated Acute Kidney Injury.Distribution of virulence-associated genes and antimicrobial susceptibility in clinical Acinetobacter baumannii isolates.BlsA integrates light and temperature signals into iron metabolism through Fur in the human pathogen Acinetobacter baumannii.
P2860
Q27701752-1D25CF1A-FE3E-460A-9689-6A213BF260EDQ36076006-4575E824-DEC1-452E-B1EF-537C42415C37Q36956080-8F5AF116-E439-4760-895C-EF580212CB11Q38641217-E84D9280-EE14-4B72-97C1-4D050E8021B1Q39038590-0E8BA25E-3B9B-4F72-BBFD-056DC633DA44Q39063044-5C34279C-0FA5-46D8-A67F-90E39BA867B9Q40617453-237AC902-57FF-4633-81BC-84B2EE803067Q40776076-E0EADE6B-F3C0-43A5-9518-F0EB66B4EEE6Q41008200-9E757727-82D5-46BB-A0AE-956D8CED19FFQ41668658-BFA06015-068C-4C86-B59C-13B1D47F4EA3Q41685804-50483A68-8A87-4276-8F36-846EEE4E6B6CQ42578968-9A028336-476E-4983-9980-AB0D81117F2AQ47103050-9C1D258C-67BC-44E1-90B9-D54A34E38214Q47785464-EC837AE7-5CC1-4DA2-ADBD-C3D1D96CB713Q48148882-A1D523D8-FFCF-4745-A758-8DCED93E92C9Q52382327-6B4C8266-B091-4FB7-8899-861BFFB437B0Q54207272-FDC292BD-1F1F-41A2-BB85-DEFE50AF184CQ55245556-2BAA030B-FCF4-4EF0-9262-4F1C029A1F44
P2860
The deadly impact of extreme drug resistance in Acinetobacter baumannii.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The deadly impact of extreme drug resistance in Acinetobacter baumannii.
@en
The deadly impact of extreme drug resistance in Acinetobacter baumannii.
@nl
type
label
The deadly impact of extreme drug resistance in Acinetobacter baumannii.
@en
The deadly impact of extreme drug resistance in Acinetobacter baumannii.
@nl
prefLabel
The deadly impact of extreme drug resistance in Acinetobacter baumannii.
@en
The deadly impact of extreme drug resistance in Acinetobacter baumannii.
@nl
P2860
P1476
The deadly impact of extreme drug resistance in Acinetobacter baumannii.
@en
P2093
Brad Spellberg
P2860
P304
P356
10.1097/CCM.0000000000000181
P407
P577
2014-05-01T00:00:00Z